Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCR201 Injection for Parkinson's Disease I/II Trial
CTR20255114Phase 2Active
- Sponsor
- Zhongsheng Suyuan
- Start
- Jan 2026
- Modality
- iPSCs → Pluripotent Stem Cells → Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of Universal iDAP in Parkinson's disease (PD), sponsored by Zhongsheng Suyuan. Started Jan 2026; status: active.
02
Drugs
Universal iDAP
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on CTR20255114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20255114.